Artificial Intelligence in Medicine: Multimodal Deep Learning and Risk Stratification
Determining the risk level of localized prostate cancer (PCa) at the time of diagnosis is often closer to an art than a science. Is it low risk, favorable intermediate risk, unfavorable intermediate risk, or high risk? Precision matters, because it determines the treatment plan’s projected probability of success. If the treatment isn’t aggressive enough, there’s […] CONTINUE
- CATEGORY:
- Artificial Intelligence